1. Home
  2. BNCWW vs YDESW Comparison

BNCWW vs YDESW Comparison

Compare BNCWW & YDESW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CEA Industries Inc. Warrant

BNCWW

CEA Industries Inc. Warrant

HOLD

Current Price

$0.02

Market Cap

0.0

Sector

N/A

ML Signal

HOLD

YDESW

YD Bio Limited Warrants

HOLD

Current Price

$0.26

Market Cap

0.0

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNCWW
YDESW
Founded
N/A
N/A
Country
United States
United States
Employees
164
15
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNCWW
YDESW
Price
$0.02
$0.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.6K
8.4K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.21
52 Week High
$0.31
$2.85

Technical Indicators

Market Signals
Indicator
BNCWW
YDESW
Relative Strength Index (RSI) 44.06 37.03
Support Level $0.02 N/A
Resistance Level $0.03 $0.36
Average True Range (ATR) 0.00 0.03
MACD 0.00 -0.00
Stochastic Oscillator 11.34 31.21

Price Performance

Historical Comparison
BNCWW
YDESW

About BNCWW CEA Industries Inc. Warrant

CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.

About YDESW YD Bio Limited Warrants

YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.

Share on Social Networks: